Invenio Imaging Completes Enrollment for AI‑Powered Lung Biopsy Study, Signaling a New Era for Rapid Tissue Assessment
Invenio Imaging Completes Enrollment for AI‑Powered Lung Biopsy Study, Signaling a New Era for Rapid Tissue Assessment. The San Jose‑based medical‑device firm announced that its pivotal ON‑SITE trial has reached full enrollment, gathering more than 3,250 fresh bronchoscopic biopsy specimens from 1,006 patients across seven U.S. centers. The study evaluates NIO® Lung Cancer Reveal, an…
